Surbhi Singhal1, James Dickerson2, Michael J Glover3, Mohana Roy2, Michelle Chiu3, Timothy Ellis-Caleo3, Gavin Hui3, Carla Tamayo4, Nele Loecher5, Hong-Nei Wong6, Lauren C Heathcote7, Lidia Schapira2. 1. Department of Medicine, Division of Medical Oncology, Stanford University, Stanford, CA, USA. singhal2@stanford.edu. 2. Department of Medicine, Division of Medical Oncology, Stanford University, Stanford, CA, USA. 3. Department of Medicine, Stanford University, Stanford, CA, USA. 4. Pravan Health Care, San Juan, PR, USA. 5. Department of Mental Health Law and Policy, University of South Florida, Tampa, FL, USA. 6. Lane Medical Library & Knowledge Management Center, Stanford University School of Medicine, Stanford, CA, USA. 7. Health Psychology Section, Department of Psychology, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, UK.
Abstract
PURPOSE: Patient-reported outcome measurements (PROMs) are increasingly used for cancer patients receiving active treatment, but little is known about the implementation and usefulness of PROMs in cancer survivorship care. This systematic review evaluates how cancer survivors and healthcare providers (HCPs) perceive PROM implementation in survivorship care, and how PROM implementation impacts cancer survivors' health outcomes. METHODS: We systematically searched PubMed/MEDLINE, Embase, CINAHL, Web of Science, and Cochrane Database of Systematic Reviews from database inception to February 2022 to identify randomized and nonrandomized studies of PROM implementation in cancer survivors. RESULTS: Based on prespecified eligibility criteria, we included 29 studies that reported on 26 unique PROMs. The studies were heterogeneous in study design, PROM instrument, patient demographics, and outcomes. Several studies found that cancer survivors and HCPs had favorable impressions of the utility of PROMs, and a few studies demonstrated that PROM implementation led to improvements in patient quality of life (QoL), with small to moderate effect sizes. CONCLUSIONS: We found implementation of PROMs in cancer survivorship care improved health outcomes for select patient populations. Future research is needed to assess the real-world utility of PROM integration into clinical workflows and the impact of PROMs on measurable health outcomes. IMPLICATIONS FOR CANCER SURVIVORS: Cancer survivors accepted PROMs. When successfully implemented, PROMs can improve health outcomes after completion of active treatment. We identify multiple avenues to strengthen PROM implementation to support cancer survivors.
PURPOSE: Patient-reported outcome measurements (PROMs) are increasingly used for cancer patients receiving active treatment, but little is known about the implementation and usefulness of PROMs in cancer survivorship care. This systematic review evaluates how cancer survivors and healthcare providers (HCPs) perceive PROM implementation in survivorship care, and how PROM implementation impacts cancer survivors' health outcomes. METHODS: We systematically searched PubMed/MEDLINE, Embase, CINAHL, Web of Science, and Cochrane Database of Systematic Reviews from database inception to February 2022 to identify randomized and nonrandomized studies of PROM implementation in cancer survivors. RESULTS: Based on prespecified eligibility criteria, we included 29 studies that reported on 26 unique PROMs. The studies were heterogeneous in study design, PROM instrument, patient demographics, and outcomes. Several studies found that cancer survivors and HCPs had favorable impressions of the utility of PROMs, and a few studies demonstrated that PROM implementation led to improvements in patient quality of life (QoL), with small to moderate effect sizes. CONCLUSIONS: We found implementation of PROMs in cancer survivorship care improved health outcomes for select patient populations. Future research is needed to assess the real-world utility of PROM integration into clinical workflows and the impact of PROMs on measurable health outcomes. IMPLICATIONS FOR CANCER SURVIVORS: Cancer survivors accepted PROMs. When successfully implemented, PROMs can improve health outcomes after completion of active treatment. We identify multiple avenues to strengthen PROM implementation to support cancer survivors.
Authors: Ruth McCorkle; Elizabeth Ercolano; Mark Lazenby; Dena Schulman-Green; Lynne S Schilling; Kate Lorig; Edward H Wagner Journal: CA Cancer J Clin Date: 2011-01-04 Impact factor: 508.702
Authors: Colleen A Cuthbert; Janine F Farragher; Brenda R Hemmelgarn; Qirui Ding; Geoffrey P McKinnon; Winson Y Cheung Journal: Psychooncology Date: 2019-10-15 Impact factor: 3.894
Authors: Lonneke V van de Poll-Franse; Nicole Horevoorts; Mies van Eenbergen; Johan Denollet; Jan Anne Roukema; Neil K Aaronson; Ad Vingerhoets; Jan Willem Coebergh; Jolanda de Vries; Marie-Louise Essink-Bot; Floortje Mols Journal: Eur J Cancer Date: 2011-05-27 Impact factor: 9.162
Authors: Ethan Basch; Xiaoyu Jia; Glenn Heller; Allison Barz; Laura Sit; Michael Fruscione; Mark Appawu; Alexia Iasonos; Thomas Atkinson; Shari Goldfarb; Ann Culkin; Mark G Kris; Deborah Schrag Journal: J Natl Cancer Inst Date: 2009-11-17 Impact factor: 13.506
Authors: Galina Velikova; Laura Booth; Adam B Smith; Paul M Brown; Pamela Lynch; Julia M Brown; Peter J Selby Journal: J Clin Oncol Date: 2004-02-15 Impact factor: 44.544
Authors: Lindsey A Torre; Rebecca L Siegel; Elizabeth M Ward; Ahmedin Jemal Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-12-14 Impact factor: 4.254
Authors: Kimberly M Davis; David Dawson; Scott Kelly; Sara Red; Sofiya Penek; John Lynch; Sean Collins; Barlow Lynch; Michael Porrazzo; Michael Bass; Kathryn L Taylor Journal: J Support Oncol Date: 2013-12